ZhuZhou QianJin Pharmaceutical Co.,Ltd

符号: 600479.SS

SHH

10.91

CNY

今天的市场价格

17.9517
市盈率
0.4616
PEG比率
4.56B
MRK市值
0.03%
DIV收益率

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) 财务报表

Q: 什么是 ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) 总资产是多少？

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 ZhuZhou QianJin Pharmaceutical Co.,Ltd 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	1997.9	1731.7	1369.7	1407.6	1378	1100.2	690.3	736.2	544.3	297	205.3	243.2	217.7	334.9	416.9	507.4	527.4	435.8	410.4	383.6	71.3	72.9	93.4
balance-sheet.row.short-term-investments	-45.7	491.7	736.8	652.3	-39.6	109.1	182.2	7.8	31.1	69.6	22.1	92.5	98.5	60.3	232	0.2	130	35	6	6.1	0	0	0.2
balance-sheet.row.net-receivables	967	983.9	921.6	1164.8	1078.8	972.4	1043	951.2	843.5	876.3	743	610.6	558.1	307.8	260.4	196.8	105.9	113.7	143.4	160.4	113.9	82.8	97.7
balance-sheet.row.inventory	534.1	599	547.8	496.8	469.5	440.9	376.3	358.5	272.3	243.2	222.5	195.3	117	126.5	98.8	96.5	82.9	87.3	75.1	84.1	84.9	71	77.5
balance-sheet.row.other-current-assets	15.4	198.9	78.1	120.2	29	82.9	319.7	87.2	267.7	27	5.6	6.7	-29.7	-12.6	-9.8	-12.1	-4.2	-7.1	-8.7	-13.2	-11.6	-13.5	-19.4
balance-sheet.row.total-current-assets	3514.5	3513.5	2917.3	3189.3	2955.3	2596.3	2429.2	2133	1927.8	1443.6	1176.4	1055.8	863.1	756.5	766.3	788.6	711.9	629.7	620.1	614.8	258.5	213.1	249.1
balance-sheet.row.property-plant-equipment-net	589.9	622.8	630.2	491	478.7	499.8	529.2	565.4	491.4	415.2	396.8	334.6	309.8	285.4	286.7	193.2	153.4	154.6	160	163	150.2	134.7	77.3
balance-sheet.row.goodwill	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	8.7	8.7	8.7	8.7	8.7	8.7	0	0	0	0	0	0
balance-sheet.row.intangible-assets	238.3	221.8	219.6	216.4	255.2	285.8	241.2	259.8	260.4	247.3	252.8	199.5	45.3	46.5	47.7	47.1	20.2	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.goodwill-and-intangible-assets	252.3	235.9	233.7	230.5	269.3	299.9	255.3	273.9	274.5	261.4	266.9	208.2	54	55.2	56.5	55.8	28.9	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.long-term-investments	293.3	-304.1	-546.1	-462	103	-63.7	-136.8	37.6	4.3	-33.2	14.2	-57.2	-57	-40.5	-86.9	13.4	54	-16.4	3.9	0.5	0	0	0.4
balance-sheet.row.tax-assets	22.7	6.6	4.1	4.2	4.2	4.6	6.9	4	3.4	2.5	2.7	1.3	2.1	0.9	0.5	0.5	1.4	0	0	0	0	0	1.3
balance-sheet.row.other-non-current-assets	4.2	547.3	821	775.7	1.7	135.7	203	18.2	41.9	139.5	31.2	102.4	109.7	71	242.8	7.9	135.6	40.7	9.8	9.7	7.9	7.6	0
balance-sheet.row.total-non-current-assets	1162.4	1108.5	1143	1039.4	856.9	876.2	857.6	899.1	815.4	785.4	711.9	589.4	418.6	371.9	499.5	270.8	373.3	199	178.1	177.7	162.8	146.8	83.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.account-payables	647.5	780.9	511.7	623	529.1	485.8	469.5	446	317	369.4	168.9	86.1	80.2	80.7	109	91.7	82	81	56.1	69.5	74.6	49.1	77.3
balance-sheet.row.short-term-debt	78.2	79.5	88.6	135.9	1.9	1	1	0.5	3.1	61	87	115.9	0	0	131	0	0	0	0	12	33.1	32.8	1.5
balance-sheet.row.tax-payables	70.6	72.5	35.6	45.2	41	61.3	67.5	32.9	23.1	41.6	28.4	28.4	34.3	10	15.2	26.6	23.7	23.2	11.3	11.6	18.9	17.1	12.9
balance-sheet.row.long-term-debt-total	38.5	44.8	60.3	19.5	20.5	26.7	37.3	47.3	54	32	5.2	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	8.7
Deferred Revenue Non Current	38	44.4	51.3	51.8	42.8	44.4	51.5	50.2	52.9	41.6	44.5	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	69.1	705.6	75.5	84.9	192.3	407.8	130.1	165.4	149.6	125	97.9	76.8	181.3	81.5	19.5	89.4	83.6	85.5	144.7	1.9	5.5	1.6	0.7
balance-sheet.row.total-non-current-liabilities	108.3	108.5	131.9	89	81.5	86.6	111.3	111.2	117.6	84.3	55.3	30	26.6	26.5	2.6	2.6	23.7	2.6	2.6	3	3.4	3.4	11.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	31.5	32.8	44.8	42.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	1650.1	1805.7	1360.3	1466.7	1182.6	1042.5	1045.7	948.2	779.2	843.2	683.9	581.2	288.1	188.6	314.5	183.7	189.3	169.1	203.4	148.4	188.2	174.3	182.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	428.9	429.8	418.5	418.5	418.5	418.5	348.8	348.8	348.8	304.8	304.8	304.8	304.8	304.8	217.7	181.4	151.2	126	84	56	38	38	38
balance-sheet.row.retained-earnings	1142.5	970.8	930.7	1047.2	959.4	826.1	694.2	568.4	481.4	456.1	414.1	377.7	328.3	328.2	356.9	295.8	260.5	115.5	60.7	122.1	114.1	71.9	57.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	280.8	275.3	298.1	298.1	297.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	537.5	540.3	503	503	503	784.2	834.4	828.5	816.7	360.6	289.3	283.5	275.2	268.6	349.4	374.2	463	399	433.8	452.5	64.8	56	40.1
balance-sheet.row.total-stockholders-equity	2389.7	2216.2	2150.4	2266.8	2178.1	2028.8	1877.4	1745.7	1646.8	1121.5	1008.2	966	908.3	901.6	924	851.4	874.6	640.6	578.5	630.6	216.9	165.8	135.4
balance-sheet.row.total-liabilities-and-stockholders-equity	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.minority-interest	637.1	600.1	549.5	495.2	451.5	401.1	363.8	338.2	317.2	264.3	196.2	98	85.3	38.2	27.3	24.3	21.3	19	16.4	13.5	16.1	19.7	14.5
balance-sheet.row.total-equity	3026.8	2816.3	2699.9	2762	2629.6	2430	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	247.6	187.6	190.8	190.3	63.4	45.3	45.3	45.3	35.3	36.3	36.3	35.3	41.6	19.8	145.1	13.6	184	18.6	10	6.5	6.5	5.5	0.5
balance-sheet.row.total-debt	116.7	124.2	148.9	155.4	22.4	27.7	38.3	47.8	57.1	93	87	115.9	0.7	0.7	131	0.7	0.7	0.7	0.7	12	33.1	32.8	1.5
balance-sheet.row.net-debt	-1881.2	-1115.7	-484	-600	-1355.5	-963.4	-469.8	-680.6	-456.1	-134.4	-96.2	-34.8	-118.5	-274	-53.9	-506.6	-396.7	-400.1	-403.7	-365.5	-38.2	-40.1	-91.7

现金流量表

在 ZhuZhou QianJin Pharmaceutical Co.,Ltd 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	395	388.3	374.7	360.2	352.1	302.6	246.7	173.4	88.3	117.7	128.8	130.9	94.8	97.6	136.9	134.5	176.6	75	61.7	46.6	48.4	38.9
cash-flows.row.depreciation-and-amortization	103.7	95.6	85.9	60.9	61.1	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1
cash-flows.row.deferred-income-tax	-2.8	-3.6	2.7	1.4	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	2.8	3.6	-2.7	-1.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-81.7	246.9	65.8	129.5	-233	29.3	-11.8	-81.8	-73.8	15.1	-49.5	40.4	-122.7	-81.4	-68.9	-88.6	2.4	47.2	-1.1	-46.4	-19.4	-45.6
cash-flows.row.account-receivables	-8.7	-163.7	275.9	27.2	-362.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	62.3	-51.2	-52.4	-27.3	-29.1	-64.7	-17.9	-85.5	-29.9	-22.4	-19.8	-78.4	9.6	-27.7	-2	-13.2	3.7	1.7	8.3	1	-13.8	3.1
cash-flows.row.account-payables	-132.5	465.4	-160.4	128.2	159.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-2.8	-3.6	2.7	1.4	-0.9	94	6.1	3.8	-44	37.4	-29.6	118.8	-132.3	-53.7	-66.8	-75.4	-1.3	45.5	-9.4	-47.4	-5.6	-48.7
cash-flows.row.other-non-cash-items	26.1	2.7	-40.9	-8.2	-24.7	-10.2	-14.1	-0.9	2.6	2.1	10.1	-13.6	12.2	-13	-19.7	-30.4	-120.6	-26.3	-7.5	-3.8	3.6	-0.3
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.acquisitions-net	0	0.2	30.8	103.6	73	0	13	0.7	85	1.2	-21.4	0.6	1.3	5.8	0.8	0.3	0.8	2.1	0.6	1	0.1	0.2
cash-flows.row.purchases-of-investments	-402	-2102	-1570	-2641	-285	-904	-1403.9	-1001.7	-769.6	-405	-135.1	-235.4	-891.1	-565.5	-1545.8	-1482	-576.3	-855.2	-1103.4	-225.3	-1	-5
cash-flows.row.sales-maturities-of-investments	1031.2	2258.4	1567.7	1770.3	469.5	1222.9	1006.1	1197.1	605.1	357.6	207.4	266.3	820.6	889.9	1194	1728.4	549.6	845.8	1107.5	219.4	0.5	0.3
cash-flows.row.other-investing-activites	0.1	0	0	-97.2	-40.6	2.5	24.3	5.9	-84.5	0.4	0.1	0	-3.9	1.6	2.8	2.8	3.1	2.4	1.8	3.7	2	1.6
cash-flows.row.net-cash-used-for-investing-activites	585.3	122.1	-43.3	-961.5	176.3	275	-417.8	120.6	-248.5	-111.8	-33.3	-224.7	-137	273.3	-471.5	154.1	-45.3	-26.3	-10.3	-57.8	-32.5	-62.2
cash-flows.row.debt-repayment	-50.7	-15	-127.6	-19.1	-6.2	-10.6	-9.5	-9.3	-105	-147	-180.9	-7.5	-20	-605	-4937	0	-550	-700	-12	-333.7	-39.7	-15.3
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-147.9	-248.6	-429.5	-209.3	-167.1	-105	-71.4	-54.4	-66.7	-60.7	-79.9	-61.3	-76.2	-108.9	-59.5	-79.6	-36.4	-96	-28.2	-32.1	-22	-7.7
cash-flows.row.other-financing-activites	-13.1	-0.5	36.5	124.2	-7.4	-9.1	-12.7	-1.2	620	154.9	180.8	125	55.2	497.8	5065.6	-1.9	548.9	698.6	0.9	711.3	41.7	58.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-202	-264.2	-520.6	-104.2	-180.7	-124.7	-93.6	-65	448.4	-52.8	-80	56.2	-41.1	-216.1	69.1	-81.5	-37.4	-97.3	-39.3	345.5	-20	35.8
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	826.4	591.4	-78.3	-523.4	151.1	533.7	-227.9	196.4	267.4	18.8	24.3	29.3	-155.4	96.3	-328.9	109.9	-3.4	-3.6	26.9	306.2	-1.5	-20.3
cash-flows.row.cash-at-end-of-period	1928.3	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9
cash-flows.row.cash-at-beginning-of-period	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9	93.2
cash-flows.row.operating-cash-flow	443.1	733.5	485.6	542.4	155.5	383.5	283.5	140.9	67.5	183.3	137.6	197.8	22.6	39.1	73.5	37.2	79.3	120.1	76.5	18.5	51	6.1
cash-flows.row.capital-expenditure	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.free-cash-flow	399.1	699	413.7	445.1	114.9	337.1	226.2	59.4	-17	117.4	53.4	-58.4	-41.3	-19.3	-49.8	-58.1	56.7	98.7	59.8	-38	16.9	-53.2

利润表行

ZhuZhou QianJin Pharmaceutical Co.,Ltd 的收入与上期相比变化了 NaN%。据报告, 600479.SS 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	3798.5	4026.3	3663.8	3627	3525.2	3328.6	3182.7	2864.9	2446.7	2194.2	1972.9	1583.4	1256.5	979.4	904.3	801.4	679.8	602.7	665.8	604.9	686.8	582	560.2
income-statement-row.row.cost-of-revenue	2046.7	2289.9	2032.2	2030.8	1918.7	1776.3	1743.2	1573.3	1311.5	1141.1	1006.8	786.3	603.5	427.9	360.8	345.8	322.3	309.4	423.8	409.4	476.1	405.9	417.3
income-statement-row.row.gross-profit	1751.8	1736.4	1631.6	1596.2	1606.5	1552.3	1439.5	1291.6	1135.2	1053.1	966	797.1	653	551.6	543.4	455.6	357.5	293.3	242	195.5	210.7	176.1	142.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.operating-expenses	3337.9	1311.7	1261.1	1224.8	1247.8	1249.1	1170.9	1111.7	1042.9	924.3	810.4	663.7	536.5	474	404.5	345.3	282.9	237.7	178	146.3	142.3	118.1	92.9
income-statement-row.row.cost-and-expenses	3337.9	3601.5	3293.4	3255.6	3166.5	3025.4	2914.1	2685	2354.4	2065.4	1817.2	1450	1140.1	901.8	765.3	691	605.2	547.1	601.8	555.7	618.4	524	510.1
income-statement-row.row.interest-income	51.4	9.8	11.9	30.4	38.6	20.9	11.7	10.9	4.6	1.2	0.2	1.7	4.1	1.6	0	0	0	2.4	1.8	3.7	1.9	1.6	1.7
income-statement-row.row.interest-expense	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.total-operating-expenses	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.interest-expense	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.depreciation-and-amortization	103.7	104.2	47.3	60.3	40.8	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1	-1.9
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	460.6	444.2	436.2	424.2	430.8	337.4	296.3	194	94.8	130.4	150	150.9	108.1	101.5	155.2	143.1	198.9	83.9	74.3	55.3	71.5	60.2	51.9
income-statement-row.row.income-before-tax	459.1	445.8	433.4	424.6	429.7	352.3	286.6	206.4	109.6	140.4	152.8	151.3	109.7	109.5	156.1	141.8	197.9	84.3	74.3	56.4	70.1	59.3	49.7
income-statement-row.row.income-tax-expense	65.4	57.6	58.7	64.4	77.6	49.7	40	33	21.3	22.7	24.1	20.4	14.9	12	19.1	7.3	21.3	9.4	12.6	9.8	21.7	20.3	14.4
income-statement-row.row.net-income	320.4	302.5	302.1	297.1	294.3	255.4	207.8	149.4	93	105.1	123.8	120.2	82.8	86.4	130.9	129.9	173.6	71.8	59.9	45.4	50.1	39.8	34.5